Idexx announces revolutionary slide-free cellular analyzer, idexx invue dx™ transforming in-clinic workflows

Ai-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases the global launch of the idexx invue dx analyzer will begin in late 2024 westbrook, maine , jan. 12, 2024 /prnewswire/ -- idexx laboratories, inc. (nasdaq: idxx), a global leader in pet healthcare innovation, announces the launch of the idexx invue dx™ cellular analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples. with deep ai learning models trained by idexx board-certified pathologists, the in-clinic analyzer provides practitioners with reference-laboratory quality results in 10 minutes.
IDXX Ratings Summary
IDXX Quant Ranking